ADS Webinar: Delirium Detection & Treatment Including Challenges Related to COVID-19

Friday, December 11, 2020 | 1PM EST | 10AM PST | 6PM GMT

Please join the American Delirium Society (ADS) for a webinar entitled, "Delirium Detection & Treatment Including Challenges Related to COVID-19" this Friday, December 11, 2020 at 1:00pm Eastern Time. We are excited about this offering and hope you will join us.

Speaker:


Alasdair MacLullich, BSc, MB ChB, MRCP(UK), PhD, FRCPE

Professor of Geriatric Medicine,
University of Edinburgh, Scotland

Alasdair's main research interests are the neuropsychology, pathophysiology, and clinical care of delirium. He has developed clinical and research tools for delirium assessment (eg. the 4AT www.the4AT.com). He co-founded the European Delirium Association and is Secretary of the Scottish Delirium Association. Alasdair co-chaired the Scottish Intercollegiate Guidelines Network group for a new national Guideline on Delirium, published in 2019. He is current Chair of the National Scottish Hip Fracture Audit Steering Group.

Moderator:


Felipe Dal Pizzol, MD, PhD
ICU Hospital Sao Jose, University of the Extreme South of Santa Catarina, Brazil

Organizers:


Roberta E.V. Castro, MD, MSc, PhD

Division of Pediatrics
Rio de Janeiro State University Brazil


Kerri Maya, RN

Program Manager of Continuing Interprofessional Development, Sutter Health Nurse Educator III, University of California, Davis

 

CE Credit

Description

Delirium detection and treatment including challenges related to COVID-19 is presented by Alasdair MacLullich, BSc, MB ChB, MRCP(UK), PhD, FRCPE. Alasdair's main research interests are the neuropsychology, pathophysiology, and clinical care of delirium. He has developed clinical and research tools for delirium assessment (e.g. the 4AT). He co-founded the European Delirium Association and is the Secretary of the Scottish Delirium Association. Alasadair co-chaired the Scottish Intercollegiate Guidelines Network (SIGN) group for a new national Guideline on Delirium Care, published in 2019.

Learning Objectives - After Viewing This Enduring Material You Should Be Able To

  1. Articulate understanding of various tools available for delirium detection & assessment
  2. Identify & implement best practices in delirium treatment (including prevention & early-intervention)
  3. Identify & address treatment challenges specific to patients with delirium related to COVID-19
  4. Articulate understanding of causes of emotional distress for delirium patients as well as treatment strategies to alleviate their suffering.

Physicians / Nurses / Pharmacists
           

In support of improving patient care, this activity has been planned and implemented by the American Delirium Society and Sutter HealthSutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Satisfactory Completion 

Learners must complete a brief evaluation form to receive a certificate of completion.

Credit Designation Statement – Sutter Health University designates this LIVE activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM for physicians and 1.0 contact hours for nurses and 1.0 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Note to Pharmacists: This is not a valid statement of credit. Credit for pharmacists and technicians will be uploaded into CPE Monitor and will be available within 60 days post activity pending submission of individual EPID number and DOB (Mo/Day).

Note to Other Disciplines: AMA PRA Category 1 Credit™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Registered Nurses, & Respiratory Care Practitioners as long as the course is from an accredited organization and has been taken within the appropriate time frames. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements.

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No financial or in-kind commercial support was received for this educational activity.

No one involved in the planning or presentation of this activity has any relevant financial relationship with a commercial interest to disclose. – Provider Designee/Verification:  Kerri Maya, MSL, RN

Credit Claiming Instructions:

  1. Go to: https://ww2.highmarksce.com/sutterhealth/index.cfm?do=cnt.page&pg=1003&signInPurpose=credits
  2. Click the “Enter Claiming Code” button. Enter the claiming code for this session: 1279-DDTxDec2020
  3. Learners must complete the session evaluation and attestation form to receive credit.
  4. Use the “View Transcript”, “View Certificate” or “Email Certificate” links to receive a copy for your records.

Questions? Email SHUCME@sutterhealth.org